Cellnovo Group announced the appointment of John Brooks as Chairman of the Board. A recognised leader in the healthcare industry, John Brooks has more than 20 years’ experience in the field of diabetes, beginning when his son was diagnosed with the condition, inspiring him to co-found Insulet, the company behind Omnipod, a tubeless insulin-pump system for type 1 diabetes. More recently, Mr. Brooks was President and Chief Executive Officer of the Joslin Diabetes Center, which is affiliated with the Harvard Medical School from 2011 to 2015.